Shashikant Lele

11.2k total citations · 2 hit papers
158 papers, 7.8k citations indexed

About

Shashikant Lele is a scholar working on Obstetrics and Gynecology, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Shashikant Lele has authored 158 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Obstetrics and Gynecology, 38 papers in Molecular Biology and 38 papers in Reproductive Medicine. Recurrent topics in Shashikant Lele's work include Ovarian cancer diagnosis and treatment (38 papers), Endometrial and Cervical Cancer Treatments (37 papers) and Immunotherapy and Immune Responses (22 papers). Shashikant Lele is often cited by papers focused on Ovarian cancer diagnosis and treatment (38 papers), Endometrial and Cervical Cancer Treatments (37 papers) and Immunotherapy and Immune Responses (22 papers). Shashikant Lele collaborates with scholars based in United States, Switzerland and Canada. Shashikant Lele's co-authors include Kunle Odunsi, Feng Qian, Lloyd J. Old, Sacha Gnjatic, Paulette Mhawech‐Fauceglia, Christine B. Ambrosone, Gerd Ritter, Protul Shrikant, Junko Matsuzaki and Amy Beck and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Shashikant Lele

156 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intraepithelial CD8⁺tumor-infiltrating lymphocytes and a high CD8⁺/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

2005 1.9k citations Feng Qian, Sacha Gnjatic et al. profile →
Tumor-infiltrating NY-ESO-1–specific CD8 ⁺ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer

2010 695 citations Junko Matsuzaki, Sacha Gnjatic et al. profile →

Peers

Countries citing papers authored by Shashikant Lele

Since Specialization

Citations

This map shows the geographic impact of Shashikant Lele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shashikant Lele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shashikant Lele more than expected).

Fields of papers citing papers by Shashikant Lele

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shashikant Lele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shashikant Lele. The network helps show where Shashikant Lele may publish in the future.

Co-authorship network of co-authors of Shashikant Lele

This figure shows the co-authorship network connecting the top 25 collaborators of Shashikant Lele. A scholar is included among the top collaborators of Shashikant Lele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shashikant Lele. Shashikant Lele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors 2023 ·Gynecologic Oncology ·Cynthia A. Thomson, Tracy E. Crane, Austin Miller, Michael A. Gold, Matthew A. Powell, Kristin Bixel, Linda Van Le, Paul DiSilvestro, Elena Ratner, Shashikant Lele, Saketh R. Guntupalli, Warner K. Huh, Sharon E. Robertson, Susan C. Modesitt, (unknown), Karen Basen‐Engquist, (unknown), Joan L. Walker, Lisa A. Kachnic, David S. Alberts	13
2	Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study 2018 ·PLoS Genetics ·Kevin H. Eng, J. Brian Szender, (unknown), Jasmine Kaur, Samantha Poblete, Ruea‐Yea Huang, Qianqian Zhu, (unknown), Sebastiano Battaglia, Rikki Cannioto, John J. Krolewski, Emese Zsíros, Peter J. Frederick, Shashikant Lele, Kirsten B. Moysich, Kunle Odunsi	9
3	FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study 2017 ·Gynecologic Oncology ·Y. Jeske, Shamshad Ali, Sara A. Byron, Feng Gao, Robert S. Mannel, Rahel Ghebre, Paul DiSilvestro, Shashikant Lele, Michael L. Pearl, Amy P. Schmidt, Heather A. Lankes, Nilsa C. Ramirez, Golnar Rasty, Matthew A. Powell, Paul J. Goodfellow, Pamela M. Pollock	41
4	An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer 2017 ·Gynecologic Oncology ·Casey Cosgrove, David Tritchler, David E. Cohn, David G. Mutch, (unknown), Heather A. Lankes, William T. Creasman, David S. Miller, Nilsa C. Ramirez, Melissa A. Geller, Matthew A. Powell, Floor Backes, Lisa M. Landrum, Cynthia Timmers, Adrian A. Suarez, Richard J. Zaino, Michael L. Pearl, Paul DiSilvestro, Shashikant Lele, Paul J. Goodfellow	92
5	A dual-channel endoscope for quantitative imaging, monitoring, and triggering of doxorubicin release from liposomes in living mice 2017 ·Scientific Reports ·(unknown), Daniel Rohrbach, Kevin A. Carter, Dandan Luo, (unknown), Semra Aygun‐Sunar, Shuai Shao, Shashikant Lele, Jonathan F. Lovell, Ulaş Sunar	15
6	Quantitative imaging of light-triggered doxorubicin release 2015 ·Biomedical Optics Express ·(unknown), Daniel Rohrbach, Kevin A. Carter, Dandan Luo, Shuai Shao, Shashikant Lele, Jonathan F. Lovell, Ulaş Sunar	15
7	Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer 2014 ·Cancer Immunology Research ·Kunle Odunsi, Junko Matsuzaki, Smitha R. James, Paulette Mhawech‐Fauceglia, Takemasa Tsuji, Austin Miller, Wa Zhang, Stacey N. Akers, Elizabeth A. Griffiths, Anthony Miliotto, Amy Beck, Carl A. Batt, Gerd Ritter, Shashikant Lele, Sacha Gnjatic, Adam R. Karpf	153
8	The role of hypoxic-inducible factor (HIF1α) and aldolaseC protein in endometrial carcinogenesis: a retrospective study of 279 patients 2012 ·BMJ Open ·Paulette Mhawech‐Fauceglia, Dan Wang, (unknown), (unknown), Heidi Godoy, (unknown), Shashikant Lele, Song Liu, Tanja Pejović	3
9	Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferation 2012 ·Cancer Immunology Immunotherapy ·Feng Qian, Jianqun Liao, Jeannine Villella, Robert P. Edwards, Paweł Kaliński, Shashikant Lele, Protul Shrikant, Kunle Odunsi	48
10	Gene Expression Profiles in Stage I Uterine Serous Carcinoma in Comparison to Grade 3 and Grade 1 Stage I Endometrioid Adenocarcinoma 2011 ·PLoS ONE ·Paulette Mhawech‐Fauceglia, Dan Wang, Joshua P. Kesterson, (unknown), Kimberly Clark, Peter J. Frederick, Shashikant Lele, Song Liu	28
11	Microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma. 2010 ·SHILAP Revista de lepidopterología ·Paulette Mhawech‐Fauceglia, (unknown), Joshua P. Kesterson, Kimberly Clark, (unknown), Kunle Odunsi, Shashikant Lele, Song Liu	2
12	IMP3 Distinguishes Uterine Serous Carcinoma From Endometrial Endometrioid Adenocarcinoma 2010 ·American Journal of Clinical Pathology ·Paulette Mhawech‐Fauceglia, François R. Herrmann, (unknown), Nana Tchabo, Shashikant Lele, Iyare Izevbaye, Kunle Odunsi, Richard T. Cheney	31
13	Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase–Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer 2009 ·Cancer Research ·Feng Qian, Jeannine Villella, Paul K. Wallace, Paulette Mhawech‐Fauceglia, Joseph D. Tario, Chris Andrews, Junko Matsuzaki, Danila Valmori, Maha Ayyoub, Peter J. Frederick, Amy Beck, Jianqun Liao, Richard Cheney, Kirsten B. Moysich, Shashikant Lele, Protul Shrikant, Lloyd J. Old, Kunle Odunsi	118
14	A rare female genital tract tumor: Benign granular cell tumor of vulva: Case report and review of the literature 2005 ·Gynecologic Oncology ·Chalong Cheewakriangkrai, Sameer Sharma, George Deeb, Shashikant Lele	13
15	Rhabdomyosarcoma of the cervix in sisterswith review of the literature 2005 ·Gynecologic Oncology ·(unknown), Péter Bogner, S. Jani-Sait, Andrea Block, Shashikant Lele	26
16	Analysis of the time interval between diagnoses in women with double primary breast and ovarian or primary peritoneal cancers 2004 ·Gynecologic Oncology ·Alexander Olawaiye, (unknown), Debra Walsh, (unknown), John Yeh, Kerry J. Rodabaugh, David L. Marchetti, Shashikant Lele, Kunle Odunsi	11
17	Human ovarian cancer, lymphoma spleen, and bovine milk GlcNAc:β1,4Gal/GalNAc transferases: two molecular species in ovarian tumor and induction of GalNAcβ1,4Glc synthesis by α-lactalbumin 2001 ·Carbohydrate Research ·E. V. Chandrasekaran, Ram Chawda, Conrad F. Piskorz, Robert D. Locke, (unknown), (unknown), Kunle Odunsi, Shashikant Lele, Khushi L. Matta	6
18	The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer. 2001 ·PubMed ·(unknown), Shashikant Lele, Shekhar Ghamande, (unknown), (unknown)	32
19	Serum α1-acid glycoprotein in epithelial ovarian cancer 1988 ·Gynecologic Oncology ·M. Steven Piver, (unknown), (unknown), Shashikant Lele, T. Ming Chu	9
20	Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas 1988 ·Journal of Surgical Oncology ·M. Steven Piver, Shashikant Lele, David L. Marchetti, Lawrence J. Emrich	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact